159 related articles for article (PubMed ID: 19483730)
1. Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway.
Liu Y; Pixley R; Fusaro M; Godoy G; Kim E; Bromberg ME; Colman RW
Oncogene; 2009 Jul; 28(30):2756-65. PubMed ID: 19483730
[TBL] [Abstract][Full Text] [Related]
2. Domain 5 of cleaved high molecular weight kininogen inhibits endothelial cell migration through Akt.
Katkade V; Soyombo AA; Isordia-Salas I; Bradford HN; Gaughan JP; Colman RW; Panetti TS
Thromb Haemost; 2005 Sep; 94(3):606-14. PubMed ID: 16268479
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells.
Cao DJ; Guo YL; Colman RW
Circ Res; 2004 May; 94(9):1227-34. PubMed ID: 15044324
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms by which cleaved kininogen inhibits endothelial cell differentiation and signalling.
Colman RW; Wu Y; Liu Y
Thromb Haemost; 2010 Nov; 104(5):875-85. PubMed ID: 20886177
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of tube formation in a collagen-fibrinogen, three-dimensional gel by cleaved kininogen (HKa) and HK domain 5 (D5) is dependent on Src family kinases.
Liu Y; Sainz IM; Wu Y; Pixley R; Espinola RG; Hassan S; Khan MM; Colman RW
Exp Cell Res; 2008 Feb; 314(4):774-88. PubMed ID: 18062965
[TBL] [Abstract][Full Text] [Related]
6. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis.
Colman RW; Jameson BA; Lin Y; Johnson D; Mousa SA
Blood; 2000 Jan; 95(2):543-50. PubMed ID: 10627460
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization.
Liu Y; Cao DJ; Sainz IM; Guo YL; Colman RW
Am J Physiol Cell Physiol; 2008 Jul; 295(1):C257-67. PubMed ID: 18495808
[TBL] [Abstract][Full Text] [Related]
9. High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytes.
Khan MM; Bradford HN; Isordia-Salas I; Liu Y; Wu Y; Espinola RG; Ghebrehiwet B; Colman RW
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2260-6. PubMed ID: 16902163
[TBL] [Abstract][Full Text] [Related]
10. Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.
Larusch GA; Merkulova A; Mahdi F; Shariat-Madar Z; Sitrin RG; Cines DB; Schmaier AH
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H305-20. PubMed ID: 23709605
[TBL] [Abstract][Full Text] [Related]
11. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
[TBL] [Abstract][Full Text] [Related]
12. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions.
Chavakis T; Kanse SM; Lupu F; Hammes HP; Müller-Esterl W; Pixley RA; Colman RW; Preissner KT
Blood; 2000 Jul; 96(2):514-22. PubMed ID: 10887113
[TBL] [Abstract][Full Text] [Related]
13. Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore).
Pixley RA; Espinola RG; Ghebrehiwet B; Joseph K; Kao A; Bdeir K; Cines DB; Colman RW
Thromb Haemost; 2011 Jun; 105(6):1053-9. PubMed ID: 21544310
[TBL] [Abstract][Full Text] [Related]
14. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases.
Guerrero J; Santibañez JF; González A; Martínez J
Exp Cell Res; 2004 Jan; 292(1):201-8. PubMed ID: 14720519
[TBL] [Abstract][Full Text] [Related]
15. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
16. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma.
Liu D; Aguirre Ghiso J; Estrada Y; Ossowski L
Cancer Cell; 2002 Jun; 1(5):445-57. PubMed ID: 12124174
[TBL] [Abstract][Full Text] [Related]
17. Cleaved high-molecular-weight kininogen inhibits neointima formation following vascular injury.
Daniel JM; Reich F; Dutzmann J; Weisheit S; Teske R; Gündüz D; Bauersachs J; Preissner KT; Sedding DG
Thromb Haemost; 2015 Aug; 114(3):603-13. PubMed ID: 26063414
[TBL] [Abstract][Full Text] [Related]
18. Kininostatin as an antiangiogenic inhibitor: what we know and what we do not know.
Guo YL; Wang S; Colman RW
Int Immunopharmacol; 2002 Dec; 2(13-14):1931-40. PubMed ID: 12489806
[TBL] [Abstract][Full Text] [Related]
19. suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion.
Piccolella M; Festuccia C; Millimaggi D; Locatelli A; Bologna M; Motta M; Dondi D
Int J Oncol; 2008 Jan; 32(1):185-91. PubMed ID: 18097558
[TBL] [Abstract][Full Text] [Related]
20. The effect of EGFR-related tyrosine kinase activity inhibition on the growth and invasion mechanisms of prostate carcinoma cell lines.
Unlü A; Leake RE
Int J Biol Markers; 2003; 18(2):139-46. PubMed ID: 12841683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
